Chembond Material Technologies Limited — Interim / Quarterly Report 2026

Jul 25, 2025

==> picture [92 x 60] intentionally omitted <==

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001 Scrip Code – 530871

To,

National Stock Exchange of India Limited Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (W), Mumbai – 400 051 Scrip Code – CHEMBOND

Ref: ISIN: INE995D01025

Sub.: Outcome of Board Meeting

Dear Sir / Madam,

In continuation to our letter bearing Ref. no. SE/CS/2025-26/45 dated July 17, 2025, and pursuant to Regulations 33, 30 and other applicable regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“the Listing Regulations”), we hereby inform you that the Board of Directors of the Company at its meeting held today considered/ noted / approved inter alia :

• i) the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2025 which are enclosed, along with the Limited Review Report; and

• ii) took note of the completion of the demerger and consequent listing of the equity shares of the Chembond Chemicals Limited (formerly Chembond Chemical Specialities Limited) with BSE Limited and National Stock Exchange on India.

The meeting of Audit Committee / Board of Directors of the Company commenced at 10.45 a.m. and concluded at 3.35 pm.

Further, pursuant to our letter Ref. No. SE/CS/2024-26/28 dated June 23, 2025 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s internal code of conduct, for prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of Board meeting i.e. till July 27, 2025.

We request you to take the above on record. Thanking you

Yours Faithfully,

For Chembond Material Technologies Limited

(formerly Chembond Chemicals Limited)

Suchita Digitally signed by Hemantkumar Singh Suchita Hemantkumar Singh Date: 2025.07.25 15:31:50 +05'30' Rashmi Sameer Digitally signed by Rashmi Sameer Gavli Date: 2025.07.25 Gavli 15:32:10 +05'30' Suchita Singh Rashmi Gavli Chief Financial Officer

Suchita Singh Company Secretary & Compliance Officer

Encl: As above

Chembond Material Technologies Limited

(formerly Chembond Chemicals Limited)

EL-71, Chembond Centre, Mahape MIDC, Navi Mumbai 400710. INDIA T: +91 22 62643000 - 03 ● F: +91 22 27681294 www.chembond.in

CIN : L24100MH1975PLC018235

S H B A & CO LLP

Chartered Accountants

Independent Auditors’ Review Report on Review of Unaudited Consolidated Interim Financial Results

Limited Review Report

To the Board of Directors of

Chembond Material Technologies Limited

1. We have reviewed the accompanying statement of unaudited consolidated financial results (‘the Statement’) of Chembond Material Technologies Limited (“the Holding Company”, formerly known as Chembond Chemicals Limited) and its subsidiary company (together referred to as “the Group”), for the quarter ended 30[th] June, 2025 being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘Listing Regulations’).

2. This Statement, which is the responsibility of the Holding Company’s management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under section 133 of the Companies Act, 2013 read with relevant rules framed there under and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review.

3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by Institute

S H B A & CO LLP Registered Office: 912, Solaris One, T: 022 6133 8000 N. S. Phadke Road, Near East-West Flyover E:info@shba.in Andheri (E), Mumbai - 400069shba.in	Branch office: G-2A, Dosti Pinnacle, Next to new Passport office, T: 022 40101995 / 2995 Road No. 22, Wagle Industrial Estate E:info@shba.in Thane (W) - 400604shba.in

S H B A & CO LLP (LLPIN: AAD–4885) [formerly known as Bathiya & Associates LLP] is a Limited Liability Partnership registered in India with limited liability under Limited Liability Partnership Act, 2008.

1

of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of Holding Company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. A review is substantially less in scope than an audit conducted in accordance ·with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under regulation 33(8) of the Listing Regulations, to the extent applicable.

1. The Statement includes the results of the following entities:

Name of the entity	Relationship
Chembond Material Technologies Limited	Holding Company
Chembond Biosciences Limited	Subsidiary Company

1. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the reports of the other auditors referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the aforesaid Indian Accounting Standards and other accounting Principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement.

2. We did not review the interim financial results of a subsidiary company, included in the Statement, whose interim financial results reflects revenue of operations of Rs. 961.51 lakhs, total net profit of Rs. 80.29 lakhs and total comprehensive income of Rs. 79.96 lakhs, included in the Statement for the quarter ended 30[th] June, 2025 respectively. These interim financial results and other financial information have been reviewed by other auditors whose reports have been furnished to us by the management of Holding Company and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of

2

these subsidiaries and associate is based solely on the report of such auditors and the procedures performed by us as stated in paragraph 3 above.

Our conclusion on the Statement is not modified in respect of these matters.

For S H B A & CO LLP

(Formerly Bathiya & Associates LLP)Chartered Accountants

Firm’s Registration No. 101046W / W100063

Jatin Digitally signed by Jatin Ashok Ashok Thakkar Thakkar Date: 2025.07.25 15:43:23 +05'30'

Jatin A. Thakkar

Partner Membership No. 134767

UDIN: 25134767BMJEVR7586

Place: Mumbai. Date: 25[th] July, 2025

3

CHEMBOND MATERIAL TECHNOLOGIES LIMITED

(formerly Chembond Chemicals Limited) CIN L24100MH1975PLC018235

Registered Office : Chembond Centre, EL 71, Mahape MIDC,Navi Mumbai - 400 710 Email id:info@chembond.in, Website:www.chembond.in Statement of Unaudited Consolidated Financial Results for the Quarter Ended 30[th] June, 2025

		(In Rs. lakhs except where stated otherwise)	(In Rs. lakhs except where stated otherwise)	(In Rs. lakhs except where stated otherwise)	(In Rs. lakhs except where stated otherwise)
Sr No	Particulars	Consolidated
		Quarter Ended			Year Ended
		30.06.2025	31.03.2025	30.06.2024	31.03.2025
		Unaudited	Audited (Refer Note 8)	Unaudited Restated	Audited
1 2 3 4 5 6 7 8 9 10 A B 11 12 13 14 15 16 17	Revenue from operations Other Income Total Income (1+2) Expenses a. Cost of materials consumed b. Changes in inventories of Finished Goods, Work-in- progress and Stock-in-trade c. Employees Benefit Expenses d. Finance Costs e. Depreciation and Amortisation Expenses f. Other Expenses Total Expenses Profit/(Loss) before exceptional item and tax (3-4) Exceptional Item Profit/(Loss) before tax (5+6) Tax Expense - Current Tax - Deferred Tax Profit/(Loss) For the Period/Year (7-8) Other Comprehenshive Income i) Items that will not be reclassified to profit or loss ii) Income Tax relating to items that will not be reclassified to profit or loss i) Items that will be reclassified to profit or loss ii) Income Tax relating to items that will be reclassified to profit or loss Other Comprehenshive Income / (loss) Total Comprehensive Income / (loss) For the Period / Year (9+10) Net profit attributable to: - Shareholders of the Company - Non Controlling Interests Other Comprehensive Income attributable to- - Shareholders of the Company - Non Controlling Interests Total Comprehensive Income / (loss) attributable to- - Shareholders of the Company - Non Controlling Interests Paid-up equity share capital (face value of Rs 5 per share) Other equity excluding Revaluation Reserve as per balance sheet Earning Per Share (amount in Rs.5 each) (not annualised for period ended) Basic EPS Diluted EPS	5,767.50 265.14 6,032.64 3,312.31 86.53 923.83 7.43 68.36 1,097.65 5,496.12 536.53 - 536.53 99.89 37.61 399.02 1.59 (0.56) - - 1.03 400.05 399.02 - 1.03 - 400.05 - 672.41 2.97 2.97	5,220.96 172.47 5,393.43 3,286.24 (218.88) 756.73 13.70 70.04 1,037.17 4,945.00 448.44 - 448.44 62.79 50.03 335.62 3.29 (0.56) - - 2.74 338.35 335.62 - 2.74 - 338.35 - 672.41 - 2.50 2.50	4,626.79 208.52 4,835.31 2,617.36 (19.25) 755.01 16.35 57.49 929.24 4,356.20 479.11 - 479.11 92.19 (80.82) 467.74 1.90 (0.56) - - 1.34 469.08 467.74 - 1.34 - 469.08 - 672.41 3.48 3.48	20,129.99 761.68 20,891.67 11,619.20 (10.85) 3,079.55 63.79 264.86 4,083.75 19,100.30 1,791.36 154.74 1,946.10 328.09 (138.23) 1,756.24 8.99 (2.23) - - 6.75 1,762.99 1,756.24 - 6.75 - 1,763.00 - 672.41 14,944.13 13.06 13.06

Notes:

• 1 These unaudited financial results of CMTL for the period ended 30th June 2025 have been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 25th July, 2025 through audio/video conferencing. The statutory auditors of the Company have carried out limited review of the Financial results of the Company for the period ended 30th June 2025.

• 2 The Group is engaged in the manufacture of Specialty Chemicals, Vitamins & Minerals, Probiotic and Prebiotic Enzymes, as well as Feed Additives and Nutrition products related to Animal Health. Under IND AS 108 – Operating Segments, specified in Section 133 of the Companies Act, 2013, these are recognized as the Group’s reportable business segments. Considering the nature of the Company’s business and based on the review of operating results by the Chief Operating Decision Maker (Board of Directors) for resource allocation and performance evaluation, the Group has identified two reportable business segments in accordance with the requirements of IND AS 108 – “Operating Segments.” (Refer note no. 10)

• 3 “Composite scheme of arrangement:

As reported in the financial results for the year ended 31st March, 2025, the comparative figures for the quarter ended 30th June 2024, 31st March, 2025 and for the year ended 31st March, 2025, have been restated pursuant to NCLT order dated 7th April, 2025, to consider the effect of demerger and amalgamation. These effects are considered as per the method of accounting prescribed in the Scheme and in accordance with principles of Indian Accounting Standards, including IND AS 103 (Business Combinations).

• 4 The Group has decided to continue with the existing tax structure as precribed under the Income Tax Act, 1961.

• 5 The Code on Social Security, 2020 ("Code") relating to employee benefits during employment and post-employment benefits has received Presidential assent and has been published in the Gazette of India. However, the effective date of the Code and final rules for quantifying the financial impact are yet to be notified. The company has started assessing the impact of the code when the relevant provisions are notified and is in the process of implementing changes in line with the Code. It does not appear that there will be any material impact to the Cost to the Company w. r. t. employee benefit expenses. As the process of implementation is underway, if there is any related impact, the same will be taken once the code becomes effective.

• 6 As at 30th June, 2025 the holding company has only one subsidiary namely Chembond Biosciences Limited whose financial results are consolidated.

• 7 Additional Information on Standalone Basis are as Follows:

Standalone Details	Year Ended Quarter Ended	Year Ended Quarter Ended	Year Ended Quarter Ended	Year Ended Quarter Ended
	30.06.2025	31.03.2025	30.06.2024	31.03.2025
	Unaudited	Audited	Unaudited Restated	Audited
Revenue from operations	4,892.03	4,444.44	3,956.16	17,120.70
Profit/(Loss) Before Tax	457.28	411.81	564.14	1,919.05
Profit/(Loss)for theperiod	316.95	296.56	551.87	1,722.36

• 8 The figures for the quarter ended 31st March, 2025 are balancing figures between audited published figures for the financial year ended 31st March, 2025 and the unaudited published figures for the nine months ended 31st December 2024, which were subject to limited review.

• 9 The figures for corresponding previous periods have been restated/regrouped, rearranged and reclassified wherever necessary to make them comparable.

BY ORDERS OF BOARD OF DIRECTORS FOR CHEMBOND MATERIAL TECHNOLOGIES LIMITED

Sameer Digitally signed by Sameer Vinod Vinod Shah Date: 2025.07.25 Shah 15:33:20 +05'30'

Place: Mumbai Date: 25th July, 2025

Sameer V. Shah Chairman and Managing Director DIN: 00105721

Note 10

Consolidated Segment wise Revenue & Results as on 30.06.2025

		(In Rs. Lakhs except where stated otherwise)	(In Rs. Lakhs except where stated otherwise)	(In Rs. Lakhs except where stated otherwise)	(In Rs. Lakhs except where stated otherwise)
**Sr No **	Particulars	Consolidated
		Quarter Ended			Year Ended
		30.06.2025 Unaudited	31.03.2025 Audited	30.06.2024 Unaudited	31.03.2025 Audited
i) ii)	Segment Revenue Specialty Chemical Biosciences(Animal Health)	4,805.99 961.51	4,358.05 862.91	3,888.72 738.07	16,848.53 3,281.46
	Net turnover	5,767.50	5,220.96	4,626.79	20,129.99
	Segment Results Profit/ (Loss) Before Interest & Tax Specialty Chemical Biosciences (Animal Health)	189.29 82.09	240.81 35.16	355.77 (85.18)	1,004.43 25.25
	Total Segment Results	271.38	275.97	270.59	1,029.68
	Unallocable Other Income	265.14	172.47	208.52	761.68
	Total Profit/(Loss) Before Tax	536.53	448.44	479.11	1,791.36

BY ORDERS OF BOARD OF DIRECTORS FOR CHEMBOND MATERIAL TECHNOLOGIES LTD

Sameer Digitally signed by Sameer Vinod Vinod Shah Date: 2025.07.25 Shah 15:33:45 +05'30'

Place: Mumbai Date: 25th July, 2025

Sameer V. Shah Chairman and Managing Director DIN: 00105721

S H B A & CO LLP

Chartered Accountants

Independent Auditors’ Review Report on Review of Unaudited Standalone Interim Financial Results

Limited Review Report

To the Board of Directors of

Chembond Material Technologies Limited

1. We have reviewed the accompanying Statement of unaudited standalone financial results of Chembond Material technologies Limited (“the Company”, formerly known as Chembond Chemicals Limited) for the quarter ended 30[th] June, 2025 (“the Statement”), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (‘Listing Regulations’).

2. This Statement, which is the responsibility of the Company’s Management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under section 133 of the Companies Act, 2013 read with relevant rules framed thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review.

3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by Institute of Chartered Accountants of India . This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of Company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. A review is substantially less in scope than an audit conducted in accordance ·with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

S H B A & CO LLP Registered Office:z Branch office: 912, Solaris One, T: 022 6133 8000 G-2A, Dosti Pinnacle, Next to new Passport office, T: 022 40101995 / N. S. Phadke Road, Near East-West Flyover E: info@shba.in 2995 Andheri (E), Mumbai - 400069 shba.in Road No. 22, Wagle Industrial Estate E: info@shba.in Thane (W) - 400604 shba.in

S H B A & CO LLP (LLPIN: AAD–4885) [formerly known as Bathiya & Associates LLP] is a Limited Liability Partnership registered in India with limited liability under Limited Liability Partnership Act, 2008.

1

1. Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with aforesaid Indian Accounting Standards and other accounting principles generally accepted in India; has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement.

==> picture [428 x 37] intentionally omitted <==

For S H B A & CO LLP

(Formerly Bathiya & Associates LLP)

Chartered Accountants Firm’s Registration No. 101046W / W100063

Digitally signed by Jatin Ashok Jatin Ashok Thakkar Thakkar Date: 2025.07.25 15:45:16 +05'30'

Jatin A. Thakkar

Partner Membership No. 134767

UDIN: 25134767BMJEVQ7400

Place: Mumbai.

Date: 25[th] July, 2025

2

CHEMBOND MATERIAL TECHNOLOGIES LIMITED

(formerly Chembond Chemicals Limited) CIN L24100MH1975PLC018235

Regd.Office: Chembond Centre, EL 71, Mahape MIDC,Navi Mumbai - 400 710 Email id:info@chembond.in, Website:www.chembond.in Standalone Unaudited Financial Results for the Quarter Ended 30[th] June, 2025

		(In Rs. lakhs except where stated otherwise)	(In Rs. lakhs except where stated otherwise)	(In Rs. lakhs except where stated otherwise)	(In Rs. lakhs except where stated otherwise)
Sr. No	Particulars		Quarter Ended		Year Ended
		30.06.2025	31.03.2025	30.06.2024	31.03.2025
		Unaudited	Audited (Refer Note 6)	Unaudited Restated	Audited
1 2 3 4 5 6 7 8 9 10 11 12 13 **14 **	Revenue from Operations Other Income Total Income (1+2) Expenses a. Cost of materials consumed b. Changes in inventories of Finished Goods, Work-in-progress and Stock-in-trade c. Employees Benefits Expense d. Finance Costs e. Depreciation and Amortisation Expenses f. Other Expenses Total Expenses Profit before exceptional Items and tax (3-4) Exceptional items Profit before tax (5+6) Tax Expense - Current Tax - Deferred Tax Profit / (loss) For the Period / Year (7-8) Other Comprehensive Income / (loss) i) Items that will not be reclassified to profit or loss ii) Income Tax relating to items that will not be reclassified to profit or loss i) Items that will be reclassified to profit or loss ii) Income Tax relating to items that will be reclassified to profit or loss Other Comprehensive Income / (loss) Total Comprehensive Income / (loss) for the period / Year (9+10) Paid-up equity share capital (face value of Rs 5 per share) Other equity Earning Per Equity Share ( Amount in Rs.5 each) (not annualised for quarter and period ended) Basic EPS (in Rs.) Diluted EPS (in Rs.)	4,892.03 264.82 5,156.85 2,819.94 78.63 773.18 4.59 67.45 955.79 4,699.57 457.28 - 457.28 85.92 54.40 316.95 1.92 (0.56) - - 1.36 318.31 672.41 2.36 2.36	4,444.44 172.24 4,616.68 2,802.45 (201.13) 622.72 1.45 69.02 910.37 4,204.89 411.80 - 411.80 68.62 46.63 296.55 1.92 (0.56) - - 1.36 297.91 672.41 2.21 2.21	3,956.16 208.41 4,164.57 2,210.48 (22.54) 605.99 2.57 56.42 747.51 3,600.43 564.14 564.14 92.19 (79.92) 551.87 1.92 (0.56) - - 1.36 553.23 672.41 4.10 4.10	17,120.70 719.97 17,840.68 9,931.25 (71.06) 2,500.40 9.05 260.68 3,446.04 16,076.36 1,764.31 154.74 1,919.05 328.06 (131.37) 1,722.36 7.67 (2.23) - - 5.43 1,727.79 672.41 15,728.11 12.81 12.81

Notes

• 1 These unaudited financial results of CMTL for the period ended 30th June, 2025 have been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 25th July, 2025 through audio/video conferencing. The statutory auditors of the Company have carried out limited review of the Financial results of the Company for the period ended 30th June, 2025.

• 2 As per Ind AS 108 - Operating Segment ('Ind AS 108'), if a financial report contains both consolidated financial statements of a parent that is within the scope of this Ind AS as well as the parent's separate financial statements, segment information is required only in the consolidated financial statements. Accordingly, information required to be presented under Ind AS 108 - Operating Segment has been given in the consolidated financial results.

• 3 The Code on Social Security, 2020 ("Code") relating to employee benefits during employment and post-employment benefits has received Presidential assent and has been published in the Gazette of India. However, the effective date of the Code and final rules for quantifying the financial impact are yet to be notified. The company has started assessing the impact of the code when the relevant provisions are notified and is in the process of implementing changes in line with the Code. It does not appear that there will be any material impact to the Cost to the Company w. r. t. employee benefit expenses. As the process of implementation is underway, if there is any related impact, the same will be taken once the code becomes effective.

• 4 “Composite scheme of arrangement:

As reported in the financial results for the year ended 31st March, 2025, the comparative figures for the quarter ended 30th June, 2024, 31st March, 2025 and for the year ended 31st March, 2025 have been restated pursuant to NCLT order dated 7th April, 2025, to consider the effect of demerger and amalgamation. These effects are considered as per the method of accounting prescribed in the Scheme and in accordance with principles of Indian Accounting Standards, including IND AS 103 (Business Combinations).

• 5 The Company has decided to continue with the existing tax structure as pre s cribed under the Income Tax Act, 1961.

• 6 The figures for the quarter ended 31st March, 2025 are balancing figures between audited published figures for the financial year ended 31st March, 2025 and the unaudited published figures for the nine months ended 31st December, 2024, which were subject to limited review.

• 7 The figures for corresponding previous periods have been restated/regrouped, rearranged and reclassified wherever necessary to make them comparable.

BY ORDERS OF BOARD OF DIRECTORS FOR CHEMBOND MATERIAL TECHNOLOGIES LIMITED

Sameer Digitally signed by Sameer Vinod Vinod Shah Date: 2025.07.25 Shah 15:34:06 +05'30'

Place: Mumbai Date: 25th July, 2025

Sameer V. Shah Chairman and Managing Director DIN: 00105721